Fig. 1
From: Construction and applications of the EOMA spheroid model of Kaposiform hemangioendothelioma
Fabrication of EOMA spheroids. A Schematic showing formation process and mechanism and applications of EOMA spheroids. B The morphology of EOMA spheroids at day 1, 2 and 3. C The diameter of EOMA spheroids at day 1, 2 and 3. D Live/Dead staining of EOMA spheroids at day 1, 2 and 3. E The viability of EOMA spheroids at day1, 2 and 3. F Phalloidine staining of EOMA spheroids at day 2. G The expression of ANG-2 in 2D EOMA cells at day 2 and EOMA spheroids at day 1, 2 and 3. H The expression of VWF in 2D EOMA cells at day 2 and EOMA spheroids at day 1, 2 and 3. *P < 0.05, compared to the 2D culture. #P < 0.05, compared to 3D-day1. Scale bars = 50 μm